TP53 and metabolic dysfunction-associated steatohepatitis: More directly, unrestrained activation of p53 is lethal in hepatocytes, p53-mediated apoptosis contributes to disease progression in a model of non-alcoholic steatohepatitis, and p53 activity promotes fibrosis in a model of chronic regeneration in rats [24–27].